Coadministration of the cyanobacterial lipopolysaccharide antagonist CyP with antibiotic inhibits cytokine production by an in vitro meningitis model infected with Neisseria meningitidis

Toll-like receptors

(2011) Eva Marie Y. Moresco et al.   CURRENT BIOLOGY

Effect of the lipopolysaccharide antagonist Planktothrix sp. FP1 cyanobacterial extract on human polymorphonuclear leukocytes

(2010) Ramòna Consuèlo Maio et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*

(2009) Mark Tidswell et al.   CRITICAL CARE MEDICINE

A Cyanobacterial Lipopolysaccharide Antagonist Inhibits Cytokine Production Induced by Neisseria meningitidis in a Human Whole-Blood Model of Septicemia

(2008) K. Jemmett et al.   INFECTION AND IMMUNITY

Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel

(2008) Maria A. Tichomirowa et al.   INTERNATIONAL JOURNAL OF CANCER

Cyanobacterial LPS antagonist (CyP)—A novel and efficient inhibitor of Escherichia coli LPS-induced cytokine response in the pig

(2008) Ebbe Billmann Thorgersen et al.   MOLECULAR IMMUNOLOGY